van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2022, ' Correction : First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (British Journal of Cancer, (2021), 124, 7, (1222-1230), 10.1038/s41416-020-01229-1) ', British Journal of Cancer, vol. 126, no. 9, pp. 1362 . https://doi.org/10.1038/s41416-022-01772-z British Journal of Cancer, 126(9). Nature Publishing Group